Gut Microbiome: A New Mechanism to Monitor Response to Biologics?
The gut microbiome is complex within irritable bowel disease (IBD), and its disruption may be a potential contributing factor in the pathogenesis of IBD.
All articles by Kwamesha Joseph
OAGB and RYGB Weight Loss Procedures Feature Similar Early Safety Profiles
The investigators aimed to report on early experience with OAGB compared to RYGB in terms of complication rates.
COVID-19: Acute Pancreatitis a Possible Symptom of Infection
COVID-19 has systemic effects that include the gastrointestinal and pancreaticobiliary systems.
Abnormal Vasculature May Distinguish Neoplastic Bile Duct Lesions on Digital Single-Operator Cholangioscopy
Can detection of irregular or spider vascularity on bile duct lesions during DSOC evaluations identify biliary neoplastic lesions? A new study examines this question.
Genetic Predictors May Determine Treatment Response in Pediatric Inflammatory Bowel Disease
This is the first study to report polymorphisms associated with long term response to anti-TNF treatment in pediatric patients with Crohn disease and ulcerative colitis.
Cannabis Use Associated with Fewer Hospital Readmissions in Patients with IBS
Lower total hospitalization costs were identified in patients with IBS who used cannabis compared with patients who did not use cannabis.
Are Patients with Inflammatory Bowel Diseases More Susceptible to COVID-19?
Inflammatory bowel diseases are known to be associated with changes in the body’s defense.
- Loading...
Loading...
Next post in Inflammatory Bowel Diseases (IBD)
Loading... 
Loading...